Business Description
GemPharmatech Co Ltd
ISIN : CNE100005964
Share Class Description:
SHSE:688046: Class ACompare
Compare
Traded in other countries / regions
688046.China IPO Date
2022-04-25Description
GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.3 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.81 | |||||
| Interest Coverage | 34.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.37 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.5 | |||||
| 3-Year EBITDA Growth Rate | 21.3 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -29 | |||||
| 3-Year Book Growth Rate | 41.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.27 | |||||
| 9-Day RSI | 50.04 | |||||
| 14-Day RSI | 50.9 | |||||
| 6-1 Month Momentum % | 26.41 | |||||
| 12-1 Month Momentum % | -27.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.91 | |||||
| Quick Ratio | 4.74 | |||||
| Cash Ratio | 3.1 | |||||
| Days Inventory | 78.56 | |||||
| Days Sales Outstanding | 172.91 | |||||
| Days Payable | 130.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.39 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| Forward Dividend Yield % | 1.39 | |||||
| 5-Year Yield-on-Cost % | 1.39 | |||||
| 3-Year Average Share Buyback Ratio | -4.4 | |||||
| Shareholder Yield % | 0.42 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.61 | |||||
| Operating Margin % | 22.11 | |||||
| Net Margin % | 20.58 | |||||
| FCF Margin % | -14.85 | |||||
| ROE % | 6.59 | |||||
| ROA % | 5.46 | |||||
| ROIC % | 12.31 | |||||
| ROC (Joel Greenblatt) % | 16.49 | |||||
| ROCE % | 6.41 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.76 | |||||
| Forward PE Ratio | 24.16 | |||||
| PE Ratio without NRI | 33.72 | |||||
| PS Ratio | 8.15 | |||||
| PB Ratio | 2.61 | |||||
| Price-to-Tangible-Book | 2.68 | |||||
| Price-to-Operating-Cash-Flow | 86.11 | |||||
| EV-to-EBIT | 33.12 | |||||
| EV-to-EBITDA | 33.12 | |||||
| EV-to-Revenue | 6.88 | |||||
| EV-to-FCF | -45.33 | |||||
| Price-to-Graham-Number | 2.01 | |||||
| Price-to-Net-Current-Asset-Value | 4.38 | |||||
| Price-to-Net-Cash | 8.56 | |||||
| Earnings Yield (Greenblatt) % | 3.02 | |||||
| FCF Yield % | -1.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GemPharmatech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 677.341 | ||
| EPS (TTM) (Â¥) | 0.34 | ||
| Beta | 0 | ||
| Volatility % | 60.59 | ||
| 14-Day RSI | 50.9 | ||
| 14-Day ATR (Â¥) | 0.693739 | ||
| 20-Day SMA (Â¥) | 13.7115 | ||
| 12-1 Month Momentum % | -27.03 | ||
| 52-Week Range (Â¥) | 9.08 - 20.8 | ||
| Shares Outstanding (Mil) | 410 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GemPharmatech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GemPharmatech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
GemPharmatech Co Ltd Frequently Asked Questions
What is GemPharmatech Co Ltd(SHSE:688046)'s stock price today?
The current price of SHSE:688046 is ¥13.52. The 52 week high of SHSE:688046 is ¥20.80 and 52 week low is ¥9.08.
When is next earnings date of GemPharmatech Co Ltd(SHSE:688046)?
The next earnings date of GemPharmatech Co Ltd(SHSE:688046) is .
Does GemPharmatech Co Ltd(SHSE:688046) pay dividends? If so, how much?
The Dividend Yield %  of GemPharmatech Co Ltd(SHSE:688046) is 1.39% (As of Today), Highest Dividend Payout Ratio of GemPharmatech Co Ltd(SHSE:688046) was 0.4. The lowest was 0.16. And the median was 0.16. The  Forward Dividend Yield % of GemPharmatech Co Ltd(SHSE:688046) is 1.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers